|
🦁
|
Rituximab in early systemic sclerosis
11 auth.
M. Boonstra,
J. Meijs,
A. Dorjée,
N. Marsan,
A. Schouffoer,
M. Ninaber,
...
K. Quint,
F. Bonte‐Mineur,
T. Huizinga,
H. Scherer,
J. D. de Vries-Bouwstra
|
5 |
2017 |
5
🦁
|
|
🐜
|
Antisense Long Non-Coding RNAs Are Deregulated in Skin Tissue of Patients with Systemic Sclerosis.
22 auth.
T. Messemaker,
L. Chadli,
G. Cai,
V. Goelela,
M. Boonstra,
A. Dorjée,
S. Andersen,
H. Mikkers,
Peter van ’t Hof,
H. Mei,
...
O. Distler,
H. Draisma,
Michael E. Johnson,
N. Orzechowski,
R. Simms,
R. Toes,
J. Aarbiou,
T. Huizinga,
M. Whitfield,
J. DeGroot,
J. D. de Vries-Bouwstra,
F. Kurreeman
|
5 |
2017 |
5
🐜
|
|
🐜
|
Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study
16 auth.
S. V. van Bijnen,
J. D. de Vries-Bouwstra,
C. V. D. van den Ende,
M. Boonstra,
L. Kroft,
B. Geurts,
M. Snoeren,
A. Schouffoer,
J. Spierings,
J. V. van Laar,
...
T. Huizinga,
A. Voskuyl,
E. Marijt,
W. J. van der Velden,
F. V. D. van den Hoogen,
M. Vonk
|
5 |
2019 |
5
🐜
|
|
🦁
|
Association of Anti–Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti–Topoisomerase I–Positive Systemic Sclerosis
13 auth.
M. Boonstra,
J. Bakker,
A. Grummels,
M. Ninaber,
N. Ajmone Marsan,
C. Wortel,
T. Huizinga,
S. Jordan,
Anna-Maria Hoffman-Vold,
O. Distler,
...
R. Toes,
H. Scherer,
J. D. de Vries-Bouwstra
|
4 |
2020 |
4
🦁
|
|
🐜
|
Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis
15 auth.
N. V. van Leeuwen,
M. Boonstra,
J. Bakker,
A. Grummels,
S. Jordan,
S. Liem,
O. Distler,
A. Hoffmann-Vold,
K. Melsens,
V. Smith,
...
M. Truchetet,
H. Scherer,
R. Toes,
T. Huizinga,
J. D. de Vries-Bouwstra
|
4 |
2021 |
4
🐜
|
|
🐜
|
Evolution of Systemic Sclerosis–Associated Interstitial Lung Disease One Year After Hematopoietic Stem Cell Transplantation or Cyclophosphamide
8 auth.
J. Ciaffi,
N. V. van Leeuwen,
M. Boonstra,
L. Kroft,
A. Schouffoer,
M. Ninaber,
...
T. Huizinga,
J. D. de Vries-Bouwstra
|
3 |
2020 |
3
🐜
|
|
🦁
|
To what extent do autoantibodies help to identify high-risk patients in systemic sclerosis?
9 auth.
M. Boonstra,
B. Mertens,
J. Bakker,
M. Ninaber,
N. Ajmone Marsan,
A. H. M. van der Helm-van Mil,
...
H. Scherer,
T. Huizinga,
J. D. de Vries-Bouwstra
|
3 |
2018 |
3
🦁
|
